Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides
✍ Scribed by Delfau-Larue, Marie-Hélène; Petrella, Tony; Lahet, Chantal; Lebozec, Christelle; Bagot, Martine; Roudot-Thoraval, Françoise; Dalac, Sophie; Farcet, Jean-Pierre; Wechsler, Janine
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 210 KB
- Volume
- 184
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
✦ Synopsis
Histological features of early mycosis fungoides (MF) can simulate numerous inflammatory lesions and histological confirmation of
MF is often delayed, compared with clinical diagnosis. Recently, using molecular techniques, the detection of a dominant T-lymphocyte clone has been reported in cutaneous lesions of MF. The aim of the present study was to determine the diagnostic value of a dominant T-lymphocyte clone as assessed by PCR-DGGE in early MF. Histopathological and molecular analyses were performed on cutaneous lesions from 104 patients clinically suspected as having MF. In this population, the positive predictive value of a PCR (+) was 0•86. In addition, four of six patients whose lesions were PCR (+) (detectable dominant T-cell clone) but not histologically MF progressed to MF within 2-48 months. In order to evaluate the relevance of PCR -DGGE in MF follow-up, serial biopsies were performed in 24 patients. In 89 per cent of cases, the presence or absence of a PCR (+) was constant during the course of the disease. When present, the DGGE imprint of PCR products was case-specific. These data demonstrate the diagnostic value in MF of T-lymphocyte clonality assessed by PCR -DGGE on cutaneous lesions and show that the technique can be used in MF follow-up to evaluate residual disease with high specificity. 1998 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
Patients with an history of carcinoma of the upper aerodigestive tract are at high risk for recurrence or the development of new tumors in this region. In the majority of follow-up protocols, these patients undergo radiologic and endoscopic evaluation as a means of surveillance for the early detecti
W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni
## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen